AstraZeneca (AZNCF)
OTC: AZNCF
· Real-Time Price · USD
155.50
-0.25 (-0.16%)
At close: Aug 15, 2025, 3:42 PM
155.75
0.16%
After-hours: Aug 13, 2025, 08:00 PM EDT
AstraZeneca Income Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 56.5B | 55.01B | 54.04B | 51.49B | 49.42B | 47.87B | 46.12B | 44.99B | 44.48B | 43.84B | 44.35B | 45.15B | 44.04B | 41.49B | 37.42B | 32.82B | 29.53B | 27.58B |
Cost of Revenue | 10.52B | 11.2B | 12.09B | 12.74B | 11.76B | 10.56B | 9.34B | 8.86B | 9.75B | 10.79B | 12.39B | 14.12B | 14.89B | 14.08B | 12.44B | 9.34B | 6.95B | 5.74B |
Gross Profit | 45.98B | 43.81B | 41.96B | 38.75B | 37.66B | 37.3B | 36.78B | 36.13B | 34.74B | 33.05B | 31.96B | 31.04B | 29.15B | 27.4B | 24.98B | 23.48B | 22.58B | 21.84B |
Operating Income | 11.32B | 10.66B | 10.22B | 9.5B | 9.35B | 8.96B | 8.28B | 8.05B | 7.34B | 5.43B | 3.76B | 2.37B | -549M | 39M | 1.06B | 2.83B | 5.68B | 5.84B |
Interest Income | 401.15M | 433.15M | 458M | 504.82M | 422.82M | 386.82M | 353.82M | 288M | 202M | 156M | 95M | 51M | 51M | 40M | 43M | 49M | 41M | 56M |
Pretax Income | 10.12B | 9.39B | 8.69B | 7.95B | 7.77B | 7.46B | 6.92B | 6.78B | 6.05B | 4.21B | 2.5B | 1.09B | -1.84B | -1.32B | -265M | 1.54B | 4.39B | 4.59B |
Net Income | 8.37B | 7.85B | 7.04B | 6.5B | 6.44B | 6.33B | 5.96B | 5.9B | 6.16B | 4.7B | 3.29B | 2.04B | -1.25B | -1.06B | 112M | 1.47B | 3.77B | 3.98B |
Selling & General & Admin | 20.42B | 20.48B | 20.53B | 19.63B | 19.27B | 19.32B | 18.89B | 19.02B | 18.49B | 18.18B | 18.95B | 19.42B | 18B | 16.39B | 14.46B | 12.53B | 11.82B | 11.36B |
Research & Development | 14.51B | 13.97B | 13.49B | 11.8B | 11.27B | 10.93B | 10.85B | 10.49B | 10.26B | 10.14B | 9.66B | 9.62B | 9.41B | 8.7B | 8.28B | 7.41B | 6.71B | 6.27B |
Other Expenses | -272.95M | -196.95M | -128M | -28M | -3M | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 1M | 1M | 1M |
Operating Expenses | 34.66B | 34.19B | 32.78B | 30.29B | 29.35B | 28.35B | 28.75B | 28.32B | 27.47B | 27.7B | 28.04B | 28.5B | 29.35B | 27.02B | 23.58B | 20.3B | 16.75B | 15.85B |
Interest Expense | 1.68B | 1.69B | 1.74B | 1.77B | 1.7B | 1.69B | 1.64B | 1.55B | 1.5B | 1.38B | 1.35B | 1.3B | 1.29B | 1.31B | 1.28B | 1.28B | 1.27B | 1.28B |
Selling & Marketing Expenses | 563M | 552M | 555M | 18.24B | 18.22B | 18.22B | 18.22B | 5.17B | 5.17B | 9.85B | 14.68B | 15.14B | 18B | 16.39B | 14.46B | 12.53B | 11.82B | 11.36B |
Cost & Expenses | 45.18B | 44.42B | 43.9B | 42.06B | 40.14B | 38.91B | 38.09B | 37.18B | 37.22B | 38.49B | 40.43B | 42.62B | 44.24B | 41.1B | 36.02B | 29.64B | 23.7B | 21.59B |
Income Tax Expense | 1.73B | 1.52B | 1.65B | 1.42B | 1.3B | 1.1B | 936.38M | 876M | -118M | -499M | -792M | -958M | -588M | -261M | -380M | 72M | 624M | 633M |
Shares Outstanding (Basic) | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.5B | 1.31B | 1.31B |
Shares Outstanding (Diluted) | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.56B | 1.55B | 1.5B | 1.32B | 1.32B |
EPS (Basic) | 5.35 | 5.01 | 4.53 | 4.20 | 4.13 | 4.08 | 3.86 | 3.82 | 4.03 | 3.07 | 2.14 | 1.32 | -0.84 | -0.65 | 0.29 | 1.29 | 2.88 | 3.04 |
EPS (Diluted) | 5.31 | 4.98 | 4.50 | 4.17 | 4.11 | 4.05 | 3.83 | 3.80 | 4.00 | 3.05 | 2.13 | 1.31 | -0.84 | -0.65 | 0.28 | 1.28 | 2.87 | 3.03 |
EBITDA | 18.52B | 17.69B | 17.11B | 15.36B | 14.48B | 14.21B | 13.63B | 13.33B | 12.58B | 10.58B | 8.85B | 8.38B | 7.03B | 7.03B | 7.58B | 7.93B | 8.8B | 8.94B |
EBIT | 11.7B | 10.97B | 10.43B | 9.64B | 9.34B | 8.95B | 8.37B | 8.19B | 7.45B | 5.53B | 3.78B | 2.37B | -542.38M | 38.75M | 1.07B | 2.82B | 5.66B | 5.82B |
Depreciation & Amortization | 6.83B | 6.72B | 6.68B | 5.71B | 5.13B | 5.14B | 5.42B | 5.58B | 5.61B | 5.63B | 5.39B | 6.06B | 7.52B | 6.95B | 6.47B | 5.06B | 3.14B | 3.11B |